Portfolio Holdings Detail for ISIN IE00B42YS929
| Stock Name / Fund | iShares MSCI World GBP Hedged UCITS ETF (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | IGWD(GBX) LSE |
| ETF Ticker | IGWD.LS(GBX) CXE |
| ETF Ticker | IGWD.L(GBP) LSE |
Holdings detail for LLY
| Stock Name | Eli Lilly and Company |
| Ticker | LLY(EUR) F |
| TYPE | Common Stock |
| Country | Germany |
| ISIN | US5324571083 |
| LEI | FRDRIPF3EKNDJ2CQJL29 |
Show aggregate LLY holdings
News associated with LLY
- Notable Friday Option Activity: AMD, LLY, BKNG
- Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
- Boost Your Portfolio With These Top-Ranked ETFs
- With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
- 3 Dividend Growth Stocks You Can Buy and Forget About
- Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
- JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
- Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
- Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
- (RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
- XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
- S&P 500 Analyst Moves: LLY
- The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot.
This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
- Why Novo Nordisk Stock Popped Today
- Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
- Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
- Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
- 3 Monster Stocks to Hold for the Next 5 Years
- Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
- 2 Beaten-Down Stocks to Buy and Hold Forever
- Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
- 2 Monster Stocks to Hold for the Next 5 Years
- Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
- IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
- Down 34%, Should You Buy the Dip on Viking Therapeutics?
- Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
- The 6 Best Stocks to Buy Right Now in September (2025)!
- My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
- The Problem With Weight Loss Stocks
- In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
- NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
- Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
- The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
- Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
- Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
- Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
- Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
- Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
- 2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
- Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
- 2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
- Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
- As the Market Rotates, This Healthcare ETF Is Leading the Way
- Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
- When AI Execs Say the Market Looks Bubbly
- In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
- Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
- Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
- The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
- Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
- The Best Stocks to Invest $50,000 in Right Now
- Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
- If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
- Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
- Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
- Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
- Warren Buffett Makes a Big Buy
- In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00
iShares MSCI World GBP Hedged UCITS ETF (Acc) LLY holdings
| Date | Number of LLY Shares Held | Base Market Value of LLY Shares | Local Market Value of LLY Shares | Change in LLY Shares Held | Change in LLY Base Value | Current Price per LLY Share Held | Previous Price per LLY Share Held |
|---|
| 2025-12-10 (Wednesday) | 5,042 | USD 3,761,070 | USD 3,761,070 | 0 | USD 36,796 | USD 745.948 | USD 738.65 |
| 2025-12-09 (Tuesday) | 5,042 | USD 3,724,274 | USD 3,724,274 | 0 | USD -54,016 | USD 738.65 | USD 749.363 |
| 2025-12-08 (Monday) | 5,042 | USD 3,778,290 | USD 3,778,290 | 0 | USD -39,572 | USD 749.363 | USD 757.212 |
| 2025-12-05 (Friday) | 5,042 | USD 3,817,862 | USD 3,817,862 | 0 | USD -6,910 | USD 757.212 | USD 758.582 |
| 2025-12-04 (Thursday) | 5,042 | USD 3,824,772 | USD 3,824,772 | 0 | USD -84,173 | USD 758.582 | USD 775.277 |
| 2025-12-03 (Wednesday) | 5,042 | USD 3,908,945 | USD 3,908,945 | -168 | USD -219,277 | USD 775.277 | USD 792.365 |
| 2025-12-02 (Tuesday) | 5,210 | USD 4,128,222 | USD 4,128,222 | 0 | USD -30,697 | USD 792.365 | USD 798.257 |
| 2025-12-01 (Monday) | 5,210 | USD 4,158,919 | USD 4,158,919 | 0 | USD -69,910 | USD 798.257 | USD 811.675 |
| 2025-11-28 (Friday) | 5,210 | USD 4,228,829 | USD 4,228,829 | 33 | USD -86,015 | USD 811.675 | USD 833.464 |
| 2025-11-27 (Thursday) | 5,177 | USD 4,314,844 | USD 4,314,844 | 0 | USD -7,339 | USD 833.464 | USD 834.882 |
| 2025-11-26 (Wednesday) | 5,177 | USD 4,322,183 | USD 4,322,183 | 0 | USD -38,732 | USD 834.882 | USD 842.363 |
| 2025-11-25 (Tuesday) | 5,177 | USD 4,360,915 | USD 4,360,915 | 0 | USD 130,933 | USD 842.363 | USD 817.072 |
| 2025-11-24 (Monday) | 5,177 | USD 4,229,982 | USD 4,229,982 | 0 | USD 105,264 | USD 817.072 | USD 796.739 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of LLY by Blackrock for IE00B42YS929
Show aggregate share trades of LLY| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-12-03 | SELL | -168 | 1,051.478 | 1,022.320 | 1,025.236 | EUR -172,240 | 626.35 Loss of -67,013 on sale |
| 2025-11-28 | BUY | 33 | 1,098.870 | 1,067.800 | 1,070.907 | EUR 35,340 | 623.84 |
| 2025-11-03 | SELL | -90 | 901.339 | 862.680 | 866.546 | EUR -77,989 | 612.15 Loss of -22,895 on sale |
| 2025-10-03 | BUY | 169 | 839.870 | 848.130 | 847.304 | EUR 143,194 | 611.80 |
| 2025-08-21 | BUY | 167 | 709.820 | 718.400 | 717.542 | EUR 119,830 | 615.99 |
| 2025-07-31 | SELL | -132 | 740.070 | 766.450 | 763.812 | EUR -100,823 | 619.62 Loss of -19,033 on sale |
| 2025-07-02 | BUY | 172 | 779.280 | 779.840 | 779.784 | EUR 134,123 | 623.48 |
| 2025-06-30 | BUY | 72 | 779.530 | 785.000 | 784.453 | EUR 56,481 | 624.27 |
| 2025-05-30 | BUY | 58 | 737.670 | 745.900 | 745.077 | EUR 43,214 | 631.53 |
| 2025-04-30 | BUY | 96 | 898.950 | 902.500 | 902.145 | EUR 86,606 | 645.81 |
| 2025-03-31 | BUY | 112 | 825.910 | 828.010 | 827.800 | EUR 92,714 | 655.75 |
| 2025-02-28 | BUY | 62 | 920.630 | 921.220 | 921.161 | EUR 57,112 | 654.51 |
| 2025-01-31 | SELL | -54 | 811.080 | 827.350 | 825.723 | EUR -44,589 | 637.61 Loss of -10,158 on sale |
| 2024-12-30 | SELL | -160 | 773.840 | 779.760 | 779.168 | EUR -124,667 | 637.62 Loss of -22,648 on sale |
| 2024-11-29 | SELL | -64 | 795.350 | 800.330 | 799.832 | EUR -51,189 | 637.42 Loss of -10,394 on sale |
| 2024-11-18 | BUY | 162 | 727.200 | 734.000 | 733.320 | EUR 118,798 | 657.76 |
| 2024-11-01 | SELL | -34 | 818.930 | 833.000 | 831.593 | EUR -28,274 | 683.47 Loss of -5,036 on sale |
| 2024-10-31 | SELL | -105 | 829.740 | 853.500 | 851.124 | EUR -89,368 | 688.23 Loss of -17,104 on sale |
| 2024-10-30 | SELL | -167 | 846.830 | 860.500 | 859.133 | EUR -143,475 | 693.56 Loss of -27,651 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of LLY
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 432,038 | 935 | 1,319,853 | 32.7% |
| 2025-09-18 | 547,818 | 126 | 1,290,147 | 42.5% |
| 2025-09-17 | 437,337 | 427 | 1,166,204 | 37.5% |
| 2025-09-16 | 532,698 | 1,829 | 1,463,374 | 36.4% |
| 2025-09-15 | 424,979 | 701 | 1,071,487 | 39.7% |
| 2025-09-12 | 267,121 | 172 | 826,802 | 32.3% |
| 2025-09-11 | 249,803 | 1,484 | 850,461 | 29.4% |
| 2025-09-10 | 415,442 | 1,025 | 989,008 | 42.0% |
| 2025-09-09 | 559,805 | 667 | 1,270,800 | 44.1% |
| 2025-09-08 | 856,018 | 4,682 | 1,937,447 | 44.2% |
| 2025-09-05 | 679,276 | 1,050 | 1,405,239 | 48.3% |
| 2025-09-04 | 337,491 | 53 | 982,751 | 34.3% |
| 2025-09-03 | 214,691 | 496 | 766,157 | 28.0% |
| 2025-09-02 | 430,477 | 2,977 | 1,131,908 | 38.0% |
| 2025-08-29 | 357,538 | 602 | 889,509 | 40.2% |
| 2025-08-28 | 433,687 | 1,099 | 1,113,568 | 38.9% |
| 2025-08-27 | 860,715 | 6,009 | 1,681,353 | 51.2% |
| 2025-08-26 | 1,548,460 | 12,105 | 2,955,348 | 52.4% |
| 2025-08-25 | 566,454 | 3,586 | 1,323,249 | 42.8% |
| 2025-08-22 | 749,615 | 1,957 | 1,460,713 | 51.3% |
| 2025-08-21 | 651,639 | 223 | 1,570,067 | 41.5% |
| 2025-08-20 | 679,554 | 2,698 | 1,870,241 | 36.3% |
| 2025-08-19 | 787,909 | 935 | 2,788,740 | 28.3% |
| 2025-08-18 | 756,143 | 1,095 | 1,727,603 | 43.8% |
| 2025-08-15 | 1,814,721 | 836 | 3,422,260 | 53.0% |
| 2025-08-14 | 1,852,940 | 5,382 | 3,602,829 | 51.4% |
| 2025-08-13 | 1,254,225 | 3,473 | 2,774,100 | 45.2% |
| 2025-08-12 | 990,110 | 3,190 | 2,845,896 | 34.8% |
| 2025-08-11 | 1,290,063 | 1,615 | 5,196,302 | 24.8% |
| 2025-08-08 | 2,448,706 | 300,870 | 6,239,830 | 39.2% |
| 2025-08-07 | 4,197,951 | 489,618 | 10,364,294 | 40.5% |
| 2025-08-06 | 440,144 | 1,120 | 1,811,262 | 24.3% |
| 2025-08-05 | 331,460 | 921 | 993,178 | 33.4% |
| 2025-08-04 | 474,905 | 1,408 | 1,273,995 | 37.3% |
| 2025-08-01 | 530,569 | 7,139 | 1,882,098 | 28.2% |
| 2025-07-31 | 882,506 | 3,670 | 2,110,030 | 41.8% |
| 2025-07-30 | 745,614 | 392 | 1,827,435 | 40.8% |
| 2025-07-29 | 1,081,849 | 571 | 2,607,245 | 41.5% |
| 2025-07-28 | 304,841 | 7,460 | 1,004,032 | 30.4% |
| 2025-07-25 | 365,417 | 265 | 1,055,273 | 34.6% |
| 2025-07-24 | 321,799 | 762 | 1,167,147 | 27.6% |
| 2025-07-23 | 485,719 | 3,471 | 1,044,919 | 46.5% |
| 2025-07-22 | 241,098 | 3,036 | 874,717 | 27.6% |
| 2025-07-21 | 418,014 | 854 | 1,180,445 | 35.4% |
| 2025-07-18 | 623,498 | 651 | 1,225,333 | 50.9% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy